Hilda Harris Piell Sells 5,753 Shares of CME Group (NASDAQ:CME) Stock

CME Group Inc. (NASDAQ:CMEGet Free Report) insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the sale, the insider owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

CME Group Stock Performance

NASDAQ CME traded down $2.75 on Tuesday, reaching $302.37. The stock had a trading volume of 2,125,712 shares, compared to its average volume of 2,303,147. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 12-month low of $257.17 and a 12-month high of $329.16. The business’s 50-day moving average price is $297.84 and its 200 day moving average price is $288.46. The stock has a market cap of $109.57 billion, a P/E ratio of 25.80, a price-to-earnings-growth ratio of 3.61 and a beta of 0.23.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The company had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.77 billion. During the same quarter in the previous year, the business earned $2.80 earnings per share. The firm’s revenue for the quarter was up 14.5% on a year-over-year basis. As a group, equities analysts expect that CME Group Inc. will post 12.26 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be paid a $1.30 dividend. The ex-dividend date is Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 1.7%. CME Group’s payout ratio is currently 44.37%.

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

Institutional Investors Weigh In On CME Group

Large investors have recently modified their holdings of the stock. Asset Dedication LLC raised its stake in shares of CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 37 shares during the last quarter. Whipplewood Advisors LLC grew its holdings in CME Group by 2,075.0% during the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 83 shares during the period. FNY Investment Advisers LLC acquired a new stake in CME Group in the fourth quarter valued at $27,000. Elkhorn Partners Limited Partnership acquired a new stake in CME Group in the fourth quarter valued at $27,000. Finally, Hilton Head Capital Partners LLC purchased a new stake in shares of CME Group during the 4th quarter worth $28,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

CME has been the subject of a number of research reports. Jefferies Financial Group reduced their price objective on CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a research note on Thursday, April 9th. Rothschild & Co Redburn cut their price target on CME Group from $340.00 to $316.00 and set a “neutral” rating for the company in a research note on Monday, April 27th. The Goldman Sachs Group cut their price target on CME Group from $275.00 to $267.00 and set a “sell” rating for the company in a research note on Thursday, April 23rd. Argus restated a “hold” rating on shares of CME Group in a research note on Wednesday, March 4th. Finally, JPMorgan Chase & Co. upped their price target on CME Group from $266.00 to $271.00 and gave the stock an “underweight” rating in a research note on Thursday, April 16th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, CME Group currently has an average rating of “Moderate Buy” and a consensus target price of $305.29.

View Our Latest Analysis on CME

CME Group Company Profile

(Get Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Featured Stories

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.